Kristal Anne Matlock1, Nana-Hawa Yayah Jones2, Sarah Dawn Corathers2, Jessica Christine Kichler3. 1. Department of Pediatrics, Division of Pediatric Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Electronic address: kristal.matlock@cchmc.org. 2. Department of Pediatrics, Division of Pediatric Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 3. Department of Pediatrics, Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Abstract
PURPOSE: This study delineates clinical and psychosocial characteristics of adolescents with type 1 diabetes and suicidal ideation (SI) and reports clinical and psychosocial outcomes after mental health intervention (safety assessment and brief in-clinic intervention). METHODS: Adolescents aged 13-17 years with type 1 diabetes completed the Children's Depression Inventory (CDI) from January 2011 to 2012. Youth with significant depressive symptoms and/or SI endorsement underwent mental health intervention. Two control subjects were matched to each adolescent endorsing SI and compared using t-tests to assess clinical and psychosocial variables. Trajectory of depressive symptoms and outcomes for case subjects were observed through January 2013. RESULTS: Twenty-seven percent (127/473) exhibited moderate to high risk for depression based on CDI scores and 38 (8%) endorsed SI. Adolescents who endorsed SI were more likely to have higher CDI scores and public insurance when compared with youth who denied SI. There was no difference in glycemic control, measured by hemoglobin A1c, between case and control groups. During the year after intervention, 28 participants who initially endorsed SI underwent repeat assessment; mean CDI scores declined by 10.57 (standard deviation: 6.92) points and 78% no longer endorsed SI. CONCLUSIONS: Given the potential lethality of insulin when taken in intentional overdose, the need for consistent identification of suicidality is an important feature of depression screening. Study findings indicate statistically significant differences in depressive symptoms and insurance status, when comparing adolescents who endorsed SI to those who denied. Improvement in depressive symptoms and SI endorsement occurred after integrating brief mental health intervention into diabetes visits.
PURPOSE: This study delineates clinical and psychosocial characteristics of adolescents with type 1 diabetes and suicidal ideation (SI) and reports clinical and psychosocial outcomes after mental health intervention (safety assessment and brief in-clinic intervention). METHODS: Adolescents aged 13-17 years with type 1 diabetes completed the Children's Depression Inventory (CDI) from January 2011 to 2012. Youth with significant depressive symptoms and/or SI endorsement underwent mental health intervention. Two control subjects were matched to each adolescent endorsing SI and compared using t-tests to assess clinical and psychosocial variables. Trajectory of depressive symptoms and outcomes for case subjects were observed through January 2013. RESULTS: Twenty-seven percent (127/473) exhibited moderate to high risk for depression based on CDI scores and 38 (8%) endorsed SI. Adolescents who endorsed SI were more likely to have higher CDI scores and public insurance when compared with youth who denied SI. There was no difference in glycemic control, measured by hemoglobin A1c, between case and control groups. During the year after intervention, 28 participants who initially endorsed SI underwent repeat assessment; mean CDI scores declined by 10.57 (standard deviation: 6.92) points and 78% no longer endorsed SI. CONCLUSIONS: Given the potential lethality of insulin when taken in intentional overdose, the need for consistent identification of suicidality is an important feature of depression screening. Study findings indicate statistically significant differences in depressive symptoms and insurance status, when comparing adolescents who endorsed SI to those who denied. Improvement in depressive symptoms and SI endorsement occurred after integrating brief mental health intervention into diabetes visits.
Authors: Shelagh A Mulvaney; Constance A Mara; Jessica C Kichler; Shideh Majidi; Kimberly A Driscoll; Sarah C Westen; Alana Rawlinson; Laura M Jacobsen; Rebecca N Adams; Korey K Hood; Maureen Monaghan Journal: Transl Behav Med Date: 2021-02-11 Impact factor: 3.046
Authors: Ashley C Moss; Alissa J Roberts; Joyce P Yi-Frazier; Kendra L Read; Craig E Taplin; Kathryn W Weaver; Catherine Pihoker; Irl B Hirsch; Faisal S Malik Journal: Diabetes Care Date: 2022-05-01 Impact factor: 17.152
Authors: Dayna E McGill; Lisa K Volkening; David M Pober; Andrew B Muir; Deborah L Young-Hyman; Lori M Laffel Journal: J Adolesc Health Date: 2017-12-06 Impact factor: 5.012
Authors: Subhankar Chatterjee; Ajay K Bakhla; Payel Biswas; Souvik Singha; Souvik Dubey; Chandra Bhushan Sharma; Subhankar Chowdhury Journal: J Family Med Prim Care Date: 2020-02-28
Authors: Maureen Monaghan; Constance A Mara; Jessica C Kichler; Sarah C Westen; Alana Rawlinson; Laura M Jacobsen; Rebecca N Adams; Jenine Y Stone; Korey K Hood; Shelagh A Mulvaney Journal: Can J Diabetes Date: 2021-01-22 Impact factor: 2.774